my country’s polyethylene glycol market structure needs to be optimized, and there is huge room for development of pharmaceutical grade products

Polyethylene glycol (PEG) is a polymer formed by the condensation of ethylene oxide and water. As a polymer material, polyethylene glycol has good moisturizing, lubricity, biocompatibility, etc., and is non-toxic and non-irritating to the human body. It is widely used in daily chemicals, medicines, paints, food, pesticides, and metals. and other fields. In the field of medicine, polyethylene glycol is mainly used to modify drugs (long-lasting, attenuated, etc.), modify medical devices (hemostasis, adhesion, anti-leakage, anti-adhesion, etc.), etc.

According to different molecular weights, polyethylene glycol can be divided into food-grade polyethylene glycol, pharmaceutical-grade polyethylene glycol, cosmetic-grade polyethylene glycol and industrial-grade polyethylene glycol. Industrial-grade polyethylene glycol is the mainstream product in the market. . The pharmaceutical field has high requirements on the molecular weight, purity, impurity content, and dispersion of polyethylene glycol. Due to technical limitations, my country’s supply of pharmaceutical-grade polyethylene glycol raw materials is insufficient, and market demand still relies on imports.

According to the “2022 Polyethylene Glycol Industry In-depth Market Research and Investment Strategy Analysis Research Report released by the Industrial Research Center, Polyethylene Glycol Industry Ethylene glycol has a wide range of applications. In recent years, with the rapid development of my country’s economy, the market demand for polyethylene glycol has continued to rise. In order to meet domestic market demand, my country’s polyethylene glycol production capacity has gradually increased. At this stage, my country’s polyethylene glycol manufacturers mainly include Oak Chemical, Beijing Coking, Tianjin Petrochemical, Jinshan Chemical, Xilong Chemical Co., Ltd., Haian Petrochemical, Jiankai Technology, etc.

JianKai Technology is a leading supplier of polyethylene glycol in China. The company is mainly engaged in the research and development, production and sales of pharmaceutical grade polyethylene glycol and its active derivatives. JianKai Technology has independent intellectual property rights in polyethylene glycol synthesis and PEGylation technology, filling the domestic technology gap. Currently, the downstream customers of JenKen Technology include foreign companies such as Covidien under Medtronic, Augmenix under Boston Scientific, Entellus under Stryker, and Cardinal Health, as well as domestic companies such as Hengrui Pharmaceuticals, Jiangsu Hansoh, and Changchun Kinsey.

In the field of medicine, polyethylene glycol is mainly used to modify protein drugs. Up to now, more than 20 polyethylene glycol-modified drugs have been approved for marketing around the world. The market size exceeds 10 billion yuan, and the market is mainly concentrated in European and American countries. Compared with the European and American markets, my country’s polyethylene glycol-modified drug market is still in its infancy, and marketed products are currently in the stage of rapid volume expansion. With the development of the polyethylene glycol modified drug market, the scale of the polyethylene glycol market will further expand.

Industry analysts said that as a polymer material, polyethylene glycol has excellent properties and a wide range of applications, including medicine, Food, daily chemicals, metal and other fields. my country is a major producer of polyethylene glycol and has excess domestic polyethylene glycol production capacity. However, domestic polyethylene glycol is mainly industrial-grade products. There is still a certain import scale of high-end polyethylene glycol such as pharmaceutical grade and cosmetic grade. In the future, my country’s polyethylene glycol The structure of the ethylene glycol industry needs to be further optimized.